Viewing nowValsartan 80 mg Tablets
Valsartan 80mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

MFDS item code 200805550 · Notified 2008.05.16 · Insurance code 643304800
Treatment of essential hypertension, reduction of the risk of death after myocardial infarction, and treatment of heart failure
This medication is used to treat essential hypertension. It is also effective for heart failure patients who cannot use ACE inhibitors, particularly for those classified as NYHA Class II to IV. It helps to reduce the mortality risk in patients with decreased left ventricular function after a myocardial infarction. It is used in the treatment of various cardiovascular diseases to improve the health condition of patients.
Take with water during or between meals. If possible, it is recommended to take this medicine at the same time each day (e.g., in the morning). 1. Essential hypertension Regardless of sex or race, the recommended dose is valsartan 80 mg orally once daily. The blood pressure-lowering effect develops gradually within 2 weeks and reaches its maximum after 4 weeks. For patients whose blood pressure is not adequately controlled, the dose may be increased to 160 mg once daily or a diuretic may be coadministered. If further blood pressure reduction is needed, the dose may be increased to a maximum of 320 mg per day. Elderly patients (75 years and older): Start treatment with 40 mg of this medicine once daily. Patients with renal impairment: Creatinine clearance 20 ∼ 50 mL/min: No dose adjustment is necessary. Creatinine clearance 10 ∼ 20 mL/min: Start treatment with 40 mg of this medicine once daily. Creatinine clearance less than 10 mL/min and patients on dialysis: Do not administer this medicine. Patients with volume depletion: For patients with intravascular volume depletion (e.g., patients taking high-dose diuretics whose dose cannot be reduced), start treatment with 40 mg of this medicine once daily. Patients with hepatic impairment: For patients with mild or moderate hepatic impairment, start treatment with 40 mg of this medicine once daily; do not exceed 80 mg per day. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis. 2. Heart failure The recommended starting dose is 40 mg of this medicine orally twice daily, and the dose may be increased to 80 mg or 160 mg per dose. When a diuretic is coadministered, consider reducing the diuretic dose. The maximum daily dose is 320 mg, administered in divided doses. Triple combination therapy with this medicine, an ACE inhibitor, and a beta-blocker is not recommended. 3. Reduction of the risk of death after myocardial infarction Treatment may be initiated within 12 hours after the onset of myocardial infarction. The recommended starting dose is 20 mg of this medicine twice daily, followed over several weeks by dose increases to 40 mg, 80 mg, and 160 mg per dose twice daily, taking the patient's tolerability into account. Consider reducing the dose if symptoms of hypotension or renal failure occur. This medicine may also be administered to patients receiving other treatments after myocardial infarction (e.g., thrombolytic agents, acetylsalicylic acid, beta-blockers, and statins). However, coadministration with an ACE inhibitor is not recommended. 4. Patients with renal impairment: No dose adjustment is necessary for creatinine clearance of 10 mL/min or greater. However, since there is no experience with use in patients with creatinine clearance less than 10 mL/min or in patients on dialysis, do not administer this medicine to these patients. 5. Patients with hepatic impairment: For patients with mild or moderate hepatic impairment, the daily dose of this medicine should preferably not exceed 80 mg. If administering 80 mg or more per day, consider whether the benefits of treatment outweigh the risks when increasing the dose. Do not administer this medicine to patients with severe hepatic impairment, cirrhosis, or cholestasis.
Essential hypertension: The safety and efficacy have not been established in children and adolescents under 18 years of age. Children: The safety and efficacy have not been established in children and adolescents under 18 years of age.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used by individuals with known allergies to this drug or its components, those with severely impaired liver or kidney function, or women who are pregnant or breastfeeding. Elderly patients or those with high serum potassium levels, or those with impaired liver function should use this medication with extra caution, as there is a risk of sudden drops in blood pressure; starting from a low dose and gradually increasing it is recommended. During treatment with this medication, side effects such as dizziness, fatigue, headache, cough, and diarrhea may occur; in rare cases, serious adverse reactions like angioedema or renal function deterioration may occur, necessitating immediate consultation with healthcare providers if symptoms manifest. This medication may interact with other antihypertensive drugs, diuretics, or potassium supplements, so it is important to inform healthcare providers of any other medications being taken, especially due to increased risk of high potassium levels, requiring regular blood tests. Pregnant or breastfeeding women should avoid taking this medication, and if breastfeeding, it is advisable to either avoid its use or discontinue breastfeeding. In case of overdose, symptoms such as hypotension or altered consciousness may occur, necessitating immediate medical attention, and it must be kept out of reach of children.
headache
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is recommended to keep it in a cool place below 30 degrees Celsius, avoiding direct sunlight or high heat.
Pale red circular film-coated tablets
98 tablets (14 tablets/PTP×7)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowValsartan 80mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Valsartan 80mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 160mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.

Valsartan 40mg
Tablet · Prescription medication
Samsung Novartis Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.
Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan
Prescription medication
Korea Sandos Co., Ltd.

Valsartan 320mg
Tablet · Prescription medication
Novartis Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.